Described herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate prescription drugs, these programs which include a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier